Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, and CardioFocus, Inc., a medical device company dedicated to advancing ...
Background: Unlike the tremendous progress made in atrial fibrillation ablation, the greatest unmet clinical need is for innovative ablation treatments for scar-related ventricular tachycardia (VT) – ...
Nathan Kastelein discusses the new Stereotaxis MAGiC Sweep EP mapping catheter's design, development and use of magnets.
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Pulse Biosciences, Inc. is one of them. Pulse Biosciences, Inc. (NASDAQ:PLSE) is advancing bioelectric medicine ...
On the silver screen, Chris Pine has played heart-stopping action heroes. Now, as narrator of podcast series “Cardiac Cowboys,” he tells the true story of the renegade medical pros who risked their ...
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no longer be controlled with medication.
Heart disease is the No. 1 killer in America, accounting for one in five deaths, according to the U.S. Centers for Disease Control and Prevention (CDC). While multiple lifestyle factors can cause ...
Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q2 2025 investor letter. A copy of the letter can be downloaded here. The Small Cap Core Strategy ...
Discontinuing oral anticoagulation (OAC) therapy resulted in a lower risk of a composite of stroke, systemic embolism or major bleeding than continuing OAC therapy in patients who had successful ...
MADRID -- Stopping oral anticoagulation after successful ablation for atrial fibrillation (AF, Afib) improved outcomes for patients without documented recurrence, the randomized ALONE-AF trial showed.